The global Pet NSAIDs market was valued at US$ 35 million in 2023 and is anticipated to reach US$ 48 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.

Pet NSAIDs Market

Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.

This report aims to provide a comprehensive presentation of the global market for Pet NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet NSAIDs.

Report Scope

The Pet NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pet NSAIDs Market Report

Report Metric	Details
Report Name	Pet NSAIDs Market
Accounted market size in 2023	US$ 35 million
Forecasted market size in 2030	US$ 48 million
CAGR	4.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Carprofen Deracoxib Firocoxib Meloxicam
Segment by Application	Dog Cat Horse Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zoetis, Elanco, PREVICOX, Metacam, Chanelle Pharma, AVENTIX, Woodruff, KRKA UK Ltd, Dechra, Parnell, VetUK, Norbrook, Alivira Animal Health, Vedco Inc, Vethical, Vetoquinol, Pivetal
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pet NSAIDs Market growing?

Ans: The Pet NSAIDs Market witnessing a CAGR of 4.1% during the forecast period 2024-2030.

What is the Pet NSAIDs Market size in 2030?

Ans: The Pet NSAIDs Market size in 2030 will be US$ 48 million.

What is the Pet NSAIDs Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet NSAIDs Market report?

Ans: The main players in the Pet NSAIDs Market are Zoetis, Elanco, PREVICOX, Metacam, Chanelle Pharma, AVENTIX, Woodruff, KRKA UK Ltd, Dechra, Parnell, VetUK, Norbrook, Alivira Animal Health, Vedco Inc, Vethical, Vetoquinol, Pivetal

What are the Application segmentation covered in the Pet NSAIDs Market report?

Ans: The Applications covered in the Pet NSAIDs Market report are Dog, Cat, Horse, Others

What are the Type segmentation covered in the Pet NSAIDs Market report?

Ans: The Types covered in the Pet NSAIDs Market report are Carprofen, Deracoxib, Firocoxib, Meloxicam

1 Pet NSAIDs Market Overview

1.1 Product Overview and Scope of Pet NSAIDs

1.2 Pet NSAIDs Segment by Type

1.2.1 Global Pet NSAIDs Market Value Comparison by Type (2024-2030)

1.2.2 Carprofen

1.2.3 Deracoxib

1.2.4 Firocoxib

1.2.5 Meloxicam

1.3 Pet NSAIDs Segment by Application

1.3.1 Global Pet NSAIDs Market Value by Application: (2024-2030)

1.3.2 Dog

1.3.3 Cat

1.3.4 Horse

1.3.5 Others

1.4 Global Pet NSAIDs Market Size Estimates and Forecasts

1.4.1 Global Pet NSAIDs Revenue 2019-2030

1.4.2 Global Pet NSAIDs Sales 2019-2030

1.4.3 Global Pet NSAIDs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pet NSAIDs Market Competition by Manufacturers

2.1 Global Pet NSAIDs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pet NSAIDs Average Price by Manufacturers (2019-2024)

2.4 Global Pet NSAIDs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pet NSAIDs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pet NSAIDs, Product Type & Application

2.7 Pet NSAIDs Market Competitive Situation and Trends

2.7.1 Pet NSAIDs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pet NSAIDs Players Market Share by Revenue

2.7.3 Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pet NSAIDs Retrospective Market Scenario by Region

3.1 Global Pet NSAIDs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pet NSAIDs Global Pet NSAIDs Sales by Region: 2019-2030

3.2.1 Global Pet NSAIDs Sales by Region: 2019-2024

3.2.2 Global Pet NSAIDs Sales by Region: 2025-2030

3.3 Global Pet NSAIDs Global Pet NSAIDs Revenue by Region: 2019-2030

3.3.1 Global Pet NSAIDs Revenue by Region: 2019-2024

3.3.2 Global Pet NSAIDs Revenue by Region: 2025-2030

3.4 North America Pet NSAIDs Market Facts & Figures by Country

3.4.1 North America Pet NSAIDs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pet NSAIDs Sales by Country (2019-2030)

3.4.3 North America Pet NSAIDs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pet NSAIDs Market Facts & Figures by Country

3.5.1 Europe Pet NSAIDs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pet NSAIDs Sales by Country (2019-2030)

3.5.3 Europe Pet NSAIDs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet NSAIDs Market Facts & Figures by Country

3.6.1 Asia Pacific Pet NSAIDs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pet NSAIDs Sales by Country (2019-2030)

3.6.3 Asia Pacific Pet NSAIDs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pet NSAIDs Market Facts & Figures by Country

3.7.1 Latin America Pet NSAIDs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pet NSAIDs Sales by Country (2019-2030)

3.7.3 Latin America Pet NSAIDs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pet NSAIDs Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet NSAIDs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pet NSAIDs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pet NSAIDs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pet NSAIDs Sales by Type (2019-2030)

4.1.1 Global Pet NSAIDs Sales by Type (2019-2024)

4.1.2 Global Pet NSAIDs Sales by Type (2025-2030)

4.1.3 Global Pet NSAIDs Sales Market Share by Type (2019-2030)

4.2 Global Pet NSAIDs Revenue by Type (2019-2030)

4.2.1 Global Pet NSAIDs Revenue by Type (2019-2024)

4.2.2 Global Pet NSAIDs Revenue by Type (2025-2030)

4.2.3 Global Pet NSAIDs Revenue Market Share by Type (2019-2030)

4.3 Global Pet NSAIDs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pet NSAIDs Sales by Application (2019-2030)

5.1.1 Global Pet NSAIDs Sales by Application (2019-2024)

5.1.2 Global Pet NSAIDs Sales by Application (2025-2030)

5.1.3 Global Pet NSAIDs Sales Market Share by Application (2019-2030)

5.2 Global Pet NSAIDs Revenue by Application (2019-2030)

5.2.1 Global Pet NSAIDs Revenue by Application (2019-2024)

5.2.2 Global Pet NSAIDs Revenue by Application (2025-2030)

5.2.3 Global Pet NSAIDs Revenue Market Share by Application (2019-2030)

5.3 Global Pet NSAIDs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Corporation Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zoetis Pet NSAIDs Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Elanco

6.2.1 Elanco Corporation Information

6.2.2 Elanco Description and Business Overview

6.2.3 Elanco Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Elanco Pet NSAIDs Product Portfolio

6.2.5 Elanco Recent Developments/Updates

6.3 PREVICOX

6.3.1 PREVICOX Corporation Information

6.3.2 PREVICOX Description and Business Overview

6.3.3 PREVICOX Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 PREVICOX Pet NSAIDs Product Portfolio

6.3.5 PREVICOX Recent Developments/Updates

6.4 Metacam

6.4.1 Metacam Corporation Information

6.4.2 Metacam Description and Business Overview

6.4.3 Metacam Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Metacam Pet NSAIDs Product Portfolio

6.4.5 Metacam Recent Developments/Updates

6.5 Chanelle Pharma

6.5.1 Chanelle Pharma Corporation Information

6.5.2 Chanelle Pharma Description and Business Overview

6.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Chanelle Pharma Pet NSAIDs Product Portfolio

6.5.5 Chanelle Pharma Recent Developments/Updates

6.6 AVENTIX

6.6.1 AVENTIX Corporation Information

6.6.2 AVENTIX Description and Business Overview

6.6.3 AVENTIX Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 AVENTIX Pet NSAIDs Product Portfolio

6.6.5 AVENTIX Recent Developments/Updates

6.7 Woodruff

6.6.1 Woodruff Corporation Information

6.6.2 Woodruff Description and Business Overview

6.6.3 Woodruff Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Woodruff Pet NSAIDs Product Portfolio

6.7.5 Woodruff Recent Developments/Updates

6.8 KRKA UK Ltd

6.8.1 KRKA UK Ltd Corporation Information

6.8.2 KRKA UK Ltd Description and Business Overview

6.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 KRKA UK Ltd Pet NSAIDs Product Portfolio

6.8.5 KRKA UK Ltd Recent Developments/Updates

6.9 Dechra

6.9.1 Dechra Corporation Information

6.9.2 Dechra Description and Business Overview

6.9.3 Dechra Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Dechra Pet NSAIDs Product Portfolio

6.9.5 Dechra Recent Developments/Updates

6.10 Parnell

6.10.1 Parnell Corporation Information

6.10.2 Parnell Description and Business Overview

6.10.3 Parnell Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Parnell Pet NSAIDs Product Portfolio

6.10.5 Parnell Recent Developments/Updates

6.11 VetUK

6.11.1 VetUK Corporation Information

6.11.2 VetUK Pet NSAIDs Description and Business Overview

6.11.3 VetUK Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 VetUK Pet NSAIDs Product Portfolio

6.11.5 VetUK Recent Developments/Updates

6.12 Norbrook

6.12.1 Norbrook Corporation Information

6.12.2 Norbrook Pet NSAIDs Description and Business Overview

6.12.3 Norbrook Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Norbrook Pet NSAIDs Product Portfolio

6.12.5 Norbrook Recent Developments/Updates

6.13 Alivira Animal Health

6.13.1 Alivira Animal Health Corporation Information

6.13.2 Alivira Animal Health Pet NSAIDs Description and Business Overview

6.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Alivira Animal Health Pet NSAIDs Product Portfolio

6.13.5 Alivira Animal Health Recent Developments/Updates

6.14 Vedco Inc

6.14.1 Vedco Inc Corporation Information

6.14.2 Vedco Inc Pet NSAIDs Description and Business Overview

6.14.3 Vedco Inc Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Vedco Inc Pet NSAIDs Product Portfolio

6.14.5 Vedco Inc Recent Developments/Updates

6.15 Vethical

6.15.1 Vethical Corporation Information

6.15.2 Vethical Pet NSAIDs Description and Business Overview

6.15.3 Vethical Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Vethical Pet NSAIDs Product Portfolio

6.15.5 Vethical Recent Developments/Updates

6.16 Vetoquinol

6.16.1 Vetoquinol Corporation Information

6.16.2 Vetoquinol Pet NSAIDs Description and Business Overview

6.16.3 Vetoquinol Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Vetoquinol Pet NSAIDs Product Portfolio

6.16.5 Vetoquinol Recent Developments/Updates

6.17 Pivetal

6.17.1 Pivetal Corporation Information

6.17.2 Pivetal Pet NSAIDs Description and Business Overview

6.17.3 Pivetal Pet NSAIDs Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Pivetal Pet NSAIDs Product Portfolio

6.17.5 Pivetal Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pet NSAIDs Industry Chain Analysis

7.2 Pet NSAIDs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet NSAIDs Production Mode & Process

7.4 Pet NSAIDs Sales and Marketing

7.4.1 Pet NSAIDs Sales Channels

7.4.2 Pet NSAIDs Distributors

7.5 Pet NSAIDs Customers

8 Pet NSAIDs Market Dynamics

8.1 Pet NSAIDs Industry Trends

8.2 Pet NSAIDs Market Drivers

8.3 Pet NSAIDs Market Challenges

8.4 Pet NSAIDs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alivira Animal Health

List of Tables

Table 1. Global Pet NSAIDs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pet NSAIDs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pet NSAIDs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pet NSAIDs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Pet NSAIDs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pet NSAIDs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pet NSAIDs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pet NSAIDs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pet NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pet NSAIDs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pet NSAIDs, Product Type & Application

Table 12. Global Key Manufacturers of Pet NSAIDs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pet NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pet NSAIDs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pet NSAIDs Sales by Region (2019-2024) & (K Units)

Table 18. Global Pet NSAIDs Sales Market Share by Region (2019-2024)

Table 19. Global Pet NSAIDs Sales by Region (2025-2030) & (K Units)

Table 20. Global Pet NSAIDs Sales Market Share by Region (2025-2030)

Table 21. Global Pet NSAIDs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pet NSAIDs Revenue Market Share by Region (2019-2024)

Table 23. Global Pet NSAIDs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pet NSAIDs Revenue Market Share by Region (2025-2030)

Table 25. North America Pet NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pet NSAIDs Sales by Country (2019-2024) & (K Units)

Table 27. North America Pet NSAIDs Sales by Country (2025-2030) & (K Units)

Table 28. North America Pet NSAIDs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pet NSAIDs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pet NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pet NSAIDs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Pet NSAIDs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Pet NSAIDs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pet NSAIDs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pet NSAIDs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pet NSAIDs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Pet NSAIDs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Pet NSAIDs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pet NSAIDs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pet NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pet NSAIDs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Pet NSAIDs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Pet NSAIDs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pet NSAIDs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pet NSAIDs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pet NSAIDs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Pet NSAIDs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Pet NSAIDs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pet NSAIDs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pet NSAIDs Sales (K Units) by Type (2019-2024)

Table 51. Global Pet NSAIDs Sales (K Units) by Type (2025-2030)

Table 52. Global Pet NSAIDs Sales Market Share by Type (2019-2024)

Table 53. Global Pet NSAIDs Sales Market Share by Type (2025-2030)

Table 54. Global Pet NSAIDs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pet NSAIDs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pet NSAIDs Revenue Market Share by Type (2019-2024)

Table 57. Global Pet NSAIDs Revenue Market Share by Type (2025-2030)

Table 58. Global Pet NSAIDs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Pet NSAIDs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Pet NSAIDs Sales (K Units) by Application (2019-2024)

Table 61. Global Pet NSAIDs Sales (K Units) by Application (2025-2030)

Table 62. Global Pet NSAIDs Sales Market Share by Application (2019-2024)

Table 63. Global Pet NSAIDs Sales Market Share by Application (2025-2030)

Table 64. Global Pet NSAIDs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pet NSAIDs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pet NSAIDs Revenue Market Share by Application (2019-2024)

Table 67. Global Pet NSAIDs Revenue Market Share by Application (2025-2030)

Table 68. Global Pet NSAIDs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Pet NSAIDs Price (US$/Unit) by Application (2025-2030)

Table 70. Zoetis Corporation Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Zoetis Pet NSAIDs Product

Table 74. Zoetis Recent Developments/Updates

Table 75. Elanco Corporation Information

Table 76. Elanco Description and Business Overview

Table 77. Elanco Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Elanco Pet NSAIDs Product

Table 79. Elanco Recent Developments/Updates

Table 80. PREVICOX Corporation Information

Table 81. PREVICOX Description and Business Overview

Table 82. PREVICOX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. PREVICOX Pet NSAIDs Product

Table 84. PREVICOX Recent Developments/Updates

Table 85. Metacam Corporation Information

Table 86. Metacam Description and Business Overview

Table 87. Metacam Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Metacam Pet NSAIDs Product

Table 89. Metacam Recent Developments/Updates

Table 90. Chanelle Pharma Corporation Information

Table 91. Chanelle Pharma Description and Business Overview

Table 92. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Chanelle Pharma Pet NSAIDs Product

Table 94. Chanelle Pharma Recent Developments/Updates

Table 95. AVENTIX Corporation Information

Table 96. AVENTIX Description and Business Overview

Table 97. AVENTIX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. AVENTIX Pet NSAIDs Product

Table 99. AVENTIX Recent Developments/Updates

Table 100. Woodruff Corporation Information

Table 101. Woodruff Description and Business Overview

Table 102. Woodruff Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Woodruff Pet NSAIDs Product

Table 104. Woodruff Recent Developments/Updates

Table 105. KRKA UK Ltd Corporation Information

Table 106. KRKA UK Ltd Description and Business Overview

Table 107. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. KRKA UK Ltd Pet NSAIDs Product

Table 109. KRKA UK Ltd Recent Developments/Updates

Table 110. Dechra Corporation Information

Table 111. Dechra Description and Business Overview

Table 112. Dechra Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Dechra Pet NSAIDs Product

Table 114. Dechra Recent Developments/Updates

Table 115. Parnell Corporation Information

Table 116. Parnell Description and Business Overview

Table 117. Parnell Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Parnell Pet NSAIDs Product

Table 119. Parnell Recent Developments/Updates

Table 120. VetUK Corporation Information

Table 121. VetUK Description and Business Overview

Table 122. VetUK Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. VetUK Pet NSAIDs Product

Table 124. VetUK Recent Developments/Updates

Table 125. Norbrook Corporation Information

Table 126. Norbrook Description and Business Overview

Table 127. Norbrook Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Norbrook Pet NSAIDs Product

Table 129. Norbrook Recent Developments/Updates

Table 130. Alivira Animal Health Corporation Information

Table 131. Alivira Animal Health Description and Business Overview

Table 132. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Alivira Animal Health Pet NSAIDs Product

Table 134. Alivira Animal Health Recent Developments/Updates

Table 135. Vedco Inc Corporation Information

Table 136. Vedco Inc Description and Business Overview

Table 137. Vedco Inc Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Vedco Inc Pet NSAIDs Product

Table 139. Vedco Inc Recent Developments/Updates

Table 140. Vethical Corporation Information

Table 141. Vethical Description and Business Overview

Table 142. Vethical Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Vethical Pet NSAIDs Product

Table 144. Vethical Recent Developments/Updates

Table 145. Vetoquinol Corporation Information

Table 146. Vetoquinol Description and Business Overview

Table 147. Vetoquinol Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Vetoquinol Pet NSAIDs Product

Table 149. Vetoquinol Recent Developments/Updates

Table 150. Pivetal Corporation Information

Table 151. Pivetal Description and Business Overview

Table 152. Pivetal Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Pivetal Pet NSAIDs Product

Table 154. Pivetal Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Pet NSAIDs Distributors List

Table 158. Pet NSAIDs Customers List

Table 159. Pet NSAIDs Market Trends

Table 160. Pet NSAIDs Market Drivers

Table 161. Pet NSAIDs Market Challenges

Table 162. Pet NSAIDs Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pet NSAIDs

Figure 2. Global Pet NSAIDs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pet NSAIDs Market Share by Type in 2023 & 2030

Figure 4. Carprofen Product Picture

Figure 5. Deracoxib Product Picture

Figure 6. Firocoxib Product Picture

Figure 7. Meloxicam Product Picture

Figure 8. Global Pet NSAIDs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Pet NSAIDs Market Share by Application in 2023 & 2030

Figure 10. Dog

Figure 11. Cat

Figure 12. Horse

Figure 13. Others

Figure 14. Global Pet NSAIDs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Pet NSAIDs Market Size (2019-2030) & (US$ Million)

Figure 16. Global Pet NSAIDs Sales (2019-2030) & (K Units)

Figure 17. Global Pet NSAIDs Average Price (US$/Unit) & (2019-2030)

Figure 18. Pet NSAIDs Report Years Considered

Figure 19. Pet NSAIDs Sales Share by Manufacturers in 2023

Figure 20. Global Pet NSAIDs Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Pet NSAIDs Players: Market Share by Revenue in 2023

Figure 22. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Pet NSAIDs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Pet NSAIDs Sales Market Share by Country (2019-2030)

Figure 25. North America Pet NSAIDs Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Pet NSAIDs Sales Market Share by Country (2019-2030)

Figure 29. Europe Pet NSAIDs Revenue Market Share by Country (2019-2030)

Figure 30. Germany Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Pet NSAIDs Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Pet NSAIDs Revenue Market Share by Region (2019-2030)

Figure 37. China Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Pet NSAIDs Sales Market Share by Country (2019-2030)

Figure 48. Latin America Pet NSAIDs Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Pet NSAIDs Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Pet NSAIDs Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. U.A.E Pet NSAIDs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Pet NSAIDs by Type (2019-2030)

Figure 58. Global Revenue Market Share of Pet NSAIDs by Type (2019-2030)

Figure 59. Global Pet NSAIDs Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Pet NSAIDs by Application (2019-2030)

Figure 61. Global Revenue Market Share of Pet NSAIDs by Application (2019-2030)

Figure 62. Global Pet NSAIDs Price (US$/Unit) by Application (2019-2030)

Figure 63. Pet NSAIDs Value Chain

Figure 64. Pet NSAIDs Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions